NRGEX | PQJCX | NRGEX / PQJCX | |
Total Expense Ratio | 0.03 | 0.95 | 3% |
Annual Report Gross Expense Ratio | 0.69 | 2.22 | 31% |
Fund Existence | 4 years | 9 years | - |
Gain YTD | -3.342 | -3.055 | 109% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.71B | 12M | 72,617% |
Annual Yield % from dividends | 0.54 | 0.25 | 215% |
Returns for 1 year | -9.46 | -8.83 | 107% |
Returns for 3 years | 8.17 | 22.64 | 36% |
Returns for 5 years | N/A | 2.37 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 75.85 | 0.47 | +0.62% |
Janus Henderson Global Life Sciences I | |||
TICSX | 7.39 | 0.04 | +0.54% |
Touchstone Small Company Instl | |||
GSVPX | 16.76 | 0.05 | +0.30% |
Goldman Sachs Small/Mid Cap Equity P | |||
RLBBX | 38.66 | 0.03 | +0.08% |
American Funds American Balanced R2 | |||
SGQCX | 42.96 | -0.03 | -0.07% |
DWS International Growth C |